Biohaven reveals positive results in migrane drug trial
Biohaven Pharmaceuticals, which recently announced a positive Stage 3 trial for one of its migraine treatments. Dr. Vlad Coric, CEO of Biohaven, discusses the future of the drug and the company with Yahoo Finance's Alexis Christoforous and Brian Sozzi